Drug Response Dx Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Liquidation

Drug Response Dx General Information

Description

Manufacturer of biomarker test intended to assess treatment results for rheumatoid arthritis. The company's tests are based on a protein that helps to predict the individual effectiveness of TNF-alpha inhibitors for each patient before medication is given, enabling patients to begin treatment quickly and resulting in a high likelihood of successful treatment.

Contact Information

Website
www.drdx.de
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Neuendorfstraße 17
  • 16761 Hennigsdorf
  • Germany
+49 03302
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Neuendorfstraße 17
  • 16761 Hennigsdorf
  • Germany
+49 03302

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Drug Response Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 07-Oct-2015 Completed Bankruptcy: Liquidation
1. Early Stage VC 07-Jan-2013 Completed Generating Revenue
To view Drug Response Dx’s complete valuation and funding history, request access »

Drug Response Dx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of biomarker test intended to assess treatment results for rheumatoid arthritis. The company's tests are ba
Diagnostic Equipment
Hennigsdorf, Germany

Cambridge, MA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Drug Response Dx Competitors (3)

One of Drug Response Dx’s 3 competitors is Avalyn Pharma, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avalyn Pharma Venture Capital-Backed Cambridge, MA
Volastra Venture Capital-Backed New York, NY
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
You’re viewing 3 of 3 competitors. Get the full list »

Ready to get started?

Request a free trial

Drug Response Dx FAQs

  • When was Drug Response Dx founded?

    Drug Response Dx was founded in 2012.

  • Where is Drug Response Dx headquartered?

    Drug Response Dx is headquartered in Hennigsdorf, Germany.

  • What industry is Drug Response Dx in?

    Drug Response Dx’s primary industry is Diagnostic Equipment.

  • Is Drug Response Dx a private or public company?

    Drug Response Dx is a Private company.

  • What is Drug Response Dx’s current revenue?

    The current revenue for Drug Response Dx is .

  • Who are Drug Response Dx’s competitors?

    Avalyn Pharma, Volastra, and Ona Therapeutics are competitors of Drug Response Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »